公开(公告)号：EP4219452A1

公开(公告)日：2023-08-02

申请号：EP23164432.9

申请日：2019-07-26

申请人： Mitsubishi Tanabe Pharma Corporation

发明人： Takahashi, Taichi ,  Takamatsu, Hisayuki ,  Iijima, Daisuke ,  Takeda, Shuzo

IPC分类号： C07D213/65 ,  C07D237/08 ,  C07D237/14 ,  C07D401/04 ,  C07D413/04 ,  C07D413/14 ,  A61K31/4412 ,  A61K31/4418 ,  A61K31/4439 ,  A61K31/444 ,  A61P35/00

摘要： Provided is a compound superior in an ATX inhibitory action and useful for the prophylaxis or treatment of diseases involving ATX. A carboxylic acid compound represented by the following formula (1) or a pharmacologically acceptable salt thereof:

wherein each symbol is as defined in the SPECIFICATION.